Galecto Inc
NASDAQ:GLTO
Galecto Inc
Retained Earnings
Galecto Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Retained Earnings
-$256.1m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Retained Earnings
kr19.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Retained Earnings
-kr5.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Retained Earnings
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Retained Earnings
kr9.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
39%
|
CAGR 10-Years
29%
|
Bioporto A/S
CSE:BIOPOR
|
Retained Earnings
-kr338m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-16%
|
See Also
What is Galecto Inc's Retained Earnings?
Retained Earnings
-256.1m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Retained Earnings amounts to -256.1m USD.
What is Galecto Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-51%
Over the last year, the Retained Earnings growth was -18%. The average annual Retained Earnings growth rates for Galecto Inc have been -35% over the past three years , -51% over the past five years .